These data indicate that piR-57125 restrains ccRCC metastasis by directly targeting CCL3 and inhibiting the AKT/ERK pathway, and could be a potential therapeutic target for ccRCC. The gene discussed is CCL3; the disease is nonpapillary renal cell carcinoma.